The emerging Kcnq2 genotype-phenotype relationship suggests loss of function variants result in neonatal epilepsy, whereas gain-of-function variants are associated with more severe symptoms including profound developmental delay, severe hypoventilation and early mortality4. Here, KCNQ2 is linked to epilepsy.